Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Drug Research
|
May 24, 2018
Inhaled Treprostinil-Prodrug Lipid Nanoparticle Formulations Provide Long-Acting Pulmonary Vasodilation
Franziska G Leifer, Donna M Konicek, Kuan-Ju Chen, et al.
Pulmonary Pharmacology & Therapeutics
|
February 9, 2018
Inhaled hexadecyl-treprostinil provides pulmonary vasodilator activity at significantly lower plasma concentrations than infused treprostinil
Richard W Chapman, Zhili Li, Michel R Corboz, et al.
International Journal of Molecular Sciences
|
January 12, 2021
Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension
Adam J Plaunt, Sadikul Islam, Tony Macaluso, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 15, 2017
Preclinical Pharmacology and Pharmacokinetics of Inhaled Hexadecyl-Treprostinil (C16TR), a Pulmonary Vasodilator Prodrug
Michel R Corboz, Zhili Li, Vladimir Malinin, et al.
Antimicrobial Agents and Chemotherapy
|
October 12, 2022
Correction for Plaunt et al., "Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections"
Adam J Plaunt, Sasha J Rose, Jeong Yeon Kang, et al.
Antimicrobial Agents and Chemotherapy
|
May 4, 2021
Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections
Adam J Plaunt, Sasha J Rose, Jeong Yeon Kang, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Drug Research
|
May 24, 2018
Inhaled Treprostinil-Prodrug Lipid Nanoparticle Formulations Provide Long-Acting Pulmonary Vasodilation
Franziska G Leifer, Donna M Konicek, Kuan-Ju Chen, et al.
Pulmonary Pharmacology & Therapeutics
|
February 9, 2018
Inhaled hexadecyl-treprostinil provides pulmonary vasodilator activity at significantly lower plasma concentrations than infused treprostinil
Richard W Chapman, Zhili Li, Michel R Corboz, et al.
International Journal of Molecular Sciences
|
January 12, 2021
Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension
Adam J Plaunt, Sadikul Islam, Tony Macaluso, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 15, 2017
Preclinical Pharmacology and Pharmacokinetics of Inhaled Hexadecyl-Treprostinil (C16TR), a Pulmonary Vasodilator Prodrug
Michel R Corboz, Zhili Li, Vladimir Malinin, et al.
Antimicrobial Agents and Chemotherapy
|
October 12, 2022
Correction for Plaunt et al., "Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections"
Adam J Plaunt, Sasha J Rose, Jeong Yeon Kang, et al.
Antimicrobial Agents and Chemotherapy
|
May 4, 2021
Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections
Adam J Plaunt, Sasha J Rose, Jeong Yeon Kang, et al.
Page
of 3